Communicate with Supplier? Supplier
Kelly Ms. Kelly
What can I do for you?
+8613375313165
Chat Now
Chat Now Contact Supplier

 Shandong Haohong Biotechnology Co., Ltd.

All
  • All
  • Title
All
  • All
  • Title
HomeProductsActive Pharmaceutical Ingredient(API)Empagliflozin API

Empagliflozin API (Total 2 Products)

Product categories of Empagliflozin API, we are specialized manufacturers from China, Empagliflozin; 864070-44-0; JARDIANCE; BI 10773; Empagliflozin (BI 10773);, Empagliflozin API suppliers/factory, wholesale high-quality products of Empagliflozin API R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
Empagliflozin API Cas 864070-44-0

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name empagliflozin X5927 2S 3R 4R 5S 6R 2 4 chloro 3 4 S tetrahydrofuran 3 yloxy benzyl phenyl 6 hydroxymethyl tetrahydro 2H pyran 3 4 5 triol Empagliflozin CS 0940 API name Empagliflozin CAS No 864070 44 0 We Shandong Haohong Biotechnology...
Pharmaceutical Raw Material Cas 864070-44-0

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name empagliflozin X5927 2S 3R 4R 5S 6R 2 4 chloro 3 4 S tetrahydrofuran 3 yloxy benzyl phenyl 6 hydroxymethyl tetrahydro 2H pyran 3 4 5 triol Empagliflozin CS 0940 API name Empagliflozin CAS No 864070 44 0 We Shandong Haohong Biotechnology...

China Empagliflozin API Suppliers

Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.

Empagliflozin is a C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a sodium-glucose transport protein subtype 2 inhibitor and a hypoglycemic agent. It is a C-glycosyl compound, an aromatic ether, a tetrahydrofuryl ether and a member of monochlorobenzenes.

Home

Product

Whatsapp

About Us

Inquiry